EDWARDS LIFESCIENCES CORP (EW)
US28176E1082 - Common Stock
Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024
Wednesday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the S&P500 gap up and gap down stocks in today's session.
Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It
Which S&P500 stocks are moving after the closing bell on Friday?
As the regular session of the US market on Friday comes to an end, let's delve into the after-hours session and discover the top S&P500 gainers and losers shaping the post-market sentiment.
Friday's after hours session: top gainers and losers
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Edwards Lifesciences Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark
The Relative Strength (RS) Rating for Edwards Lifesciences stock jumped into a new percentile Tuesday, with a rise from 78 to 81.
Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR
Interesting EW Put And Call Options For April 19th
Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
Edwards Lifesciences Dips On In-Line Profit, Narrow Sales Beat
The company narrowly topped sales expectations and adjusted profit came in line.
Edwards Lifesciences Non-GAAP EPS of $0.64 in-line, revenue of $1.53B beats by $30M (NYSE:EW)
Edwards Lifesciences reported Q4 Non-GAAP EPS in-line with expectations and beat revenue estimates by $30M, showing a 13.3% YoY growth.
Edwards Lifesciences Reports Fourth Quarter Results
Notable earnings after Tuesday's close
Major earnings expected after the bell on Tuesday include:Ford Motor Company (F)Gilead Sciences (GILD)Amgen (AMGN)Enphase Energy (ENPH) Snap (SNAP)Other...
Edwards stock jumps 8% on FDA approval, Wells Fargo upgrade (NYSE:EW)
Edwards Lifesciences (EW) stock rallied 8% midday Friday in the wake of an FDA approval for its Evoque heart valve device and an upgrade by Wells Fargo. Read more here.
Edwards gets FDA okay for Evoque tricuspid valve replacement system (NYSE:EW)
Edwards (EW) said that it has received FDA approval for its Evoque tricuspid valve replacement system for the treatment of tricuspid regurgitation. The medical
Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve
Wednesday Sector Leaders: Utilities, Healthcare
S&P 500 Movers: ROK, PARA
Edwards Lifesciences Breaks Above 200-Day Moving Average - Bullish for EW
